EHHADH and hepatocellular carcinoma: Our findings revealed that HCC patients with high EHHADH mRNA levels exhibited a significantly improved overall survival (OS) compared to those with low levels (hazard ratio [HR] = 0.67, p < 0.05; Figure 1i).